Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Aug;34(2):96–101. doi: 10.1111/j.1365-2125.1992.tb04116.x

Avoiding nitrate tolerance.

J C Cowan 1
PMCID: PMC1381524  PMID: 1419477

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J. Interval therapy to avoid nitrate tolerance: paradise regained? Am J Cardiol. 1989 Oct 15;64(14):931–934. doi: 10.1016/0002-9149(89)90844-8. [DOI] [PubMed] [Google Scholar]
  2. Bassan M. M., Weiler-Ravell D. The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effect. Chest. 1983 Feb;83(2):233–240. doi: 10.1378/chest.83.2.233. [DOI] [PubMed] [Google Scholar]
  3. Cerri B., Grasso F., Cefis M., Pollavini G. Comparative evaluation of the effect of two doses of Nitroderm TTS on exercise-related parameters in patients with angina pectoris. Eur Heart J. 1984 Sep;5(9):710–715. doi: 10.1093/oxfordjournals.eurheartj.a061731. [DOI] [PubMed] [Google Scholar]
  4. Cowan J. C., Bourke J. P., Reid D. S., Julian D. G. Prevention of tolerance to nitroglycerin patches by overnight removal. Am J Cardiol. 1987 Aug 1;60(4):271–275. doi: 10.1016/0002-9149(87)90226-8. [DOI] [PubMed] [Google Scholar]
  5. Cowan J. C. Nitrate tolerance. Int J Cardiol. 1986 Jul;12(1):1–19. doi: 10.1016/0167-5273(86)90094-x. [DOI] [PubMed] [Google Scholar]
  6. Crean P. A., Ribeiro P., Crea F., Davies G. J., Ratcliffe D., Maseri A. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial. Am Heart J. 1984 Dec;108(6):1494–1500. doi: 10.1016/0002-8703(84)90697-5. [DOI] [PubMed] [Google Scholar]
  7. Dakak N., Makhoul N., Flugelman M. Y., Merdler A., Shehadeh H., Schneeweiss A., Halon D. A., Lewis B. S. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1990 Sep 1;66(5):608–613. doi: 10.1016/0002-9149(90)90489-n. [DOI] [PubMed] [Google Scholar]
  8. DeMots H., Glasser S. P. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989 Mar 15;13(4):786–795. doi: 10.1016/0735-1097(89)90216-7. [DOI] [PubMed] [Google Scholar]
  9. Dupuis J., Lalonde G., Lebeau R., Bichet D., Rouleau J. L. Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. Am Heart J. 1990 Sep;120(3):625–637. doi: 10.1016/0002-8703(90)90021-o. [DOI] [PubMed] [Google Scholar]
  10. Elkayam U., Kulick D., McIntosh N., Roth A., Hsueh W., Rahimtoola S. H. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation. 1987 Sep;76(3):577–584. doi: 10.1161/01.cir.76.3.577. [DOI] [PubMed] [Google Scholar]
  11. Ferratini M., Pirelli S., Merlini P., Silva P., Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule. Eur Heart J. 1989 Nov;10(11):998–1002. doi: 10.1093/oxfordjournals.eurheartj.a059425. [DOI] [PubMed] [Google Scholar]
  12. Fox K. M., Dargie H. J., Deanfield J., Maseri A. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators. Br Heart J. 1991 Aug;66(2):151–155. doi: 10.1136/hrt.66.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fung H. L., Chong S., Kowaluk E., Hough K., Kakemi M. Mechanisms for the pharmacologic interaction of organic nitrates with thiols. Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine. J Pharmacol Exp Ther. 1988 May;245(2):524–530. [PubMed] [Google Scholar]
  14. Ignarro L. J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989 Jul;65(1):1–21. doi: 10.1161/01.res.65.1.1. [DOI] [PubMed] [Google Scholar]
  15. Jugdutt B. I., Warnica J. W. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation. 1988 Oct;78(4):906–919. doi: 10.1161/01.cir.78.4.906. [DOI] [PubMed] [Google Scholar]
  16. Katz R. J., Levy W. S., Buff L., Wasserman A. G. Prevention of nitrate tolerance with angiotension converting enzyme inhibitors. Circulation. 1991 Apr;83(4):1271–1277. doi: 10.1161/01.cir.83.4.1271. [DOI] [PubMed] [Google Scholar]
  17. Lange R. L., Reid M. S., Tresch D. D., Keelan M. H., Bernhard V. M., Coolidge G. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation. 1972 Oct;46(4):666–678. doi: 10.1161/01.cir.46.4.666. [DOI] [PubMed] [Google Scholar]
  18. Lis Y., Bennett D., Lambert G., Robson D. A preliminary double-blind study of intravenous nitroglycerin in acute myocardial infarction. Intensive Care Med. 1984;10(4):179–184. doi: 10.1007/BF00259434. [DOI] [PubMed] [Google Scholar]
  19. Luke R., Sharpe N., Coxon R. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application. J Am Coll Cardiol. 1987 Sep;10(3):642–646. doi: 10.1016/s0735-1097(87)80208-5. [DOI] [PubMed] [Google Scholar]
  20. Lüscher T. F. Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. Eur Heart J. 1989 Sep;10(9):847–857. doi: 10.1093/oxfordjournals.eurheartj.a059580. [DOI] [PubMed] [Google Scholar]
  21. Morton W. E. Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension. J Occup Med. 1977 Mar;19(3):197–200. [PubMed] [Google Scholar]
  22. Mulcahy D., Keegan J., Cunningham D., Quyyumi A., Crean P., Park A., Wright C., Fox K. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet. 1988 Oct 1;2(8614):755–759. doi: 10.1016/s0140-6736(88)92414-2. [DOI] [PubMed] [Google Scholar]
  23. Münzel T., Holtz J., Mülsch A., Stewart D. J., Bassenge E. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist. Circulation. 1989 Jan;79(1):188–197. doi: 10.1161/01.cir.79.1.188. [DOI] [PubMed] [Google Scholar]
  24. Needleman P., Jakschik B., Johnson E. M., Jr Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther. 1973 Nov;187(2):324–331. [PubMed] [Google Scholar]
  25. Needleman P., Johnson E. M., Jr Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther. 1973 Mar;184(3):709–715. [PubMed] [Google Scholar]
  26. Packer M., Medina N., Yushak M., Lee W. H. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure. Am J Cardiol. 1986 Feb 1;57(4):260–267. doi: 10.1016/0002-9149(86)90902-1. [DOI] [PubMed] [Google Scholar]
  27. Parker J. O., Case R. B., Khaja F., Ledwich J. R., Armstrong P. W. The influence of changes in blood volume on angina pectoris. A study of the effect of phlebotomy. Circulation. 1970 Apr;41(4):593–604. doi: 10.1161/01.cir.41.4.593. [DOI] [PubMed] [Google Scholar]
  28. Parker J. O., Farrell B., Lahey K. A., Moe G. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med. 1987 Jun 4;316(23):1440–1444. doi: 10.1056/NEJM198706043162303. [DOI] [PubMed] [Google Scholar]
  29. Parker J. O., Farrell B., Lahey K. A., Rose B. F. Nitrate tolerance: the lack of effect of N-acetylcysteine. Circulation. 1987 Sep;76(3):572–576. doi: 10.1161/01.cir.76.3.572. [DOI] [PubMed] [Google Scholar]
  30. Parker J. O., Fung H. L. Transdermal nitroglycerin in angina pectoris. Am J Cardiol. 1984 Sep 1;54(6):471–476. doi: 10.1016/0002-9149(84)90233-9. [DOI] [PubMed] [Google Scholar]
  31. Parker J. O. Nitrate therapy in stable angina pectoris. N Engl J Med. 1987 Jun 25;316(26):1635–1642. doi: 10.1056/NEJM198706253162606. [DOI] [PubMed] [Google Scholar]
  32. Parker J. O., Vankoughnett K. A., Farrell B. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris. Am J Cardiol. 1985 Nov 1;56(12):724–728. doi: 10.1016/0002-9149(85)91123-3. [DOI] [PubMed] [Google Scholar]
  33. Rafflenbeul W., Bassenge E., Lichtlen P. Konkurrenz zwischen endothelabhängiger und Nitroglygerin-induzierter koronarer Vasodilatation [Competition between endothelium-dependent and nitroglycerin-induced coronary vasodilation]. Z Kardiol. 1989;78 (Suppl 2):45–67. [PubMed] [Google Scholar]
  34. Rezaković D. E., Stalec J. Acute and chronic efficacy of 10 mg of nitroglycerin patch in stable angina pectoris. Am J Cardiol. 1988 Mar 25;61(9):52E–58E. doi: 10.1016/0002-9149(88)90091-4. [DOI] [PubMed] [Google Scholar]
  35. Rudolph W., Blasini R., Reiniger G., Brügmann U. Tolerance development during isosorbide dinitrate treatment: can it be circumvented? Z Kardiol. 1983;72 (Suppl 3):195–198. [PubMed] [Google Scholar]
  36. Russek H. I. Propranolol and isosorbide dinitrate synergism in angina pectoris. Am J Cardiol. 1968 Jan;21(1):44–54. doi: 10.1016/0002-9149(68)90012-x. [DOI] [PubMed] [Google Scholar]
  37. Scardi S., Camerini F., Pandullo C., Pollavini G. Efficacy of continuous and intermittent transdermal treatment with nitroglycerin in effort angina pectoris: a multicentric study. The Collaborative Nitro Group. Int J Cardiol. 1991 Aug;32(2):241–248. doi: 10.1016/0167-5273(91)90331-i. [DOI] [PubMed] [Google Scholar]
  38. Schaer D. H., Buff L. A., Katz R. J. Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. Am J Cardiol. 1988 Jan 1;61(1):46–50. doi: 10.1016/0002-9149(88)91302-1. [DOI] [PubMed] [Google Scholar]
  39. Silber S., Krause K. H., Garner C., Theisen K., Jahrmärker H. Anti-ischemic effects of an 80-mg tablet of isosorbide dinitrate in sustained-release form before and after 2 weeks treatment with 80 mg once daily or twice daily. Z Kardiol. 1983;72 (Suppl 3):211–217. [PubMed] [Google Scholar]
  40. Silber S., Vogler A. C., Krause K. H., Vogel M., Theisen K. Induction and circumvention of nitrate tolerance applying different dosage intervals. Am J Med. 1987 Nov;83(5):860–870. doi: 10.1016/0002-9343(87)90643-7. [DOI] [PubMed] [Google Scholar]
  41. Stewart D. J., Elsner D., Sommer O., Holtz J., Bassenge E. Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency. Circulation. 1986 Sep;74(3):573–582. doi: 10.1161/01.cir.74.3.573. [DOI] [PubMed] [Google Scholar]
  42. Thadani U., Fung H. L., Darke A. C., Parker J. O. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 1;49(2):411–419. doi: 10.1016/0002-9149(82)90518-5. [DOI] [PubMed] [Google Scholar]
  43. Vanhoutte P. M., Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation. 1989 Jul;80(1):1–9. doi: 10.1161/01.cir.80.1.1. [DOI] [PubMed] [Google Scholar]
  44. Wisenberg G., Roks C., Nichol P., Goddard M. D. Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris. Am J Cardiol. 1989 Sep 15;64(10):569–576. doi: 10.1016/0002-9149(89)90480-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES